• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Stepan Reports Second Quarter 2025 Results

    7/30/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $SCL alert in real time by email

    NORTHBROOK, Ill., July 30, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported:

    Stepan Company Logo (PRNewsfoto/Stepan Company)

    Second Quarter 2025 Highlights

    • Reported net income was $11.3 million, up 19% versus the prior year.  Adjusted net income(1) was $12.0 million, up 27% versus the prior year, driven by earnings growth within Polymers, our Crop Productivity business and a lower effective tax rate. 
    • EBITDA(2)  was $50.6 million and Adjusted EBITDA(2) was $51.4 million, up 6% and 8% respectively, year-over-year.
    • Global sales volume was up 1% year-over-year.       
    • Cash from Operations was $11.2 million during the quarter.  Free cash flow(3) for the quarter was a negative $14.4 million, primarily due to increased working capital needs to support business growth, build inventory ahead of anticipated  tariffs, and maintain safety stock in preparation for the hurricane season and a new collective bargaining agreement at our Millsdale site.
    • Pre-tax earnings were negatively impacted by $6.1 million primarily due to start-up costs associated with our new alkoxylation site in Pasadena, Texas, and an environmental remediation reserve adjustment at our Millsdale site.

    First Half 2025 Highlights

    • Reported net income was $31.1 million, up 33% versus the prior year.  Adjusted net income(1) was $31.3 million, up 30% versus the prior year.
    • EBITDA(2)  was $108.6 million and Adjusted EBITDA(2) was $108.9 million, up 11% and 10% respectively, year-over-year.
    • Global sales volume was up 2% year-over-year.  

    "Quarterly earnings were up double digits driven by improved Polymer and Crop Productivity results as well as a lower effective tax rate.  Polymer volume was up 7% as the North American Rigid, European Rigid and Phthalic Anhydride businesses all delivered volume growth.  Within Surfactants, we also continued to experience double digit volume growth within the Agricultural and Oilfield end markets.  This growth was offset by lower demand within the global commodity Consumer Products end markets," said Luis E. Rojo, President and Chief Executive Officer.  "Second quarter adjusted EBITDA grew 8% and adjusted EBITDA is up 10% for the first half despite higher start-up expenses at our Pasadena site, the negative one-time events and a significant run up in Oleochemical raw material costs that we are planning to recover during the second half of the year.  We remain encouraged by the growth within several of our key strategic end markets and we believe in our ability to recover raw material inflation gradually.  Free cash flow was negative primarily due to inventory builds. As previously communicated, our new alkoxylation site in Pasadena, Texas is now operational and will provide benefits in the second half of the year and going forward."

    Financial Summary





    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands, except per share data)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Net Sales



    $

    594,689





    $

    556,405







    7

    %



    $

    1,187,944





    $

    1,107,823







    7

    %

    Operating Income



    $

    17,965





    $

    18,667







    (4)

    %



    $

    46,253





    $

    38,836







    19

    %

    Net Income



    $

    11,341





    $

    9,521







    19

    %



    $

    31,052





    $

    23,414







    33

    %

    Earnings per Diluted Share



    $

    0.50





    $

    0.42







    19

    %



    $

    1.36





    $

    1.02







    33

    %







































    Adjusted Net Income *



    $

    11,952





    $

    9,396







    27

    %



    $

    31,262





    $

    24,052







    30

    %

    Adjusted Earnings per

       Diluted Share *



    $

    0.52





    $

    0.41







    27

    %



    $

    1.37





    $

    1.05







    30

    %

    * See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.



    Percentage Change in Net Sales

    Net sales in the second quarter of 2025 increased 7% year-over-year.  This increase was primarily driven by higher selling prices that were mainly attributable to the pass-through of higher raw material costs and more favorable product mix.   





    Three Months Ended

    June 30, 2025





    Six Months Ended

    June 30, 2025



    Volume





    1

    %





    2

    %

    Selling Price & Mix





    6

    %





    7

    %

    Foreign Translation





    (—)

    %





    (2)

    %

    Total





    7

    %





    7

    %

    Segment Results





    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Net Sales





































    Surfactants



    $

    411,456





    $

    379,795







    8

    %



    $

    841,793





    $

    770,615







    9

    %

    Polymers



    $

    162,751





    $

    159,757







    2

    %



    $

    308,867





    $

    305,265







    1

    %

    Specialty Products



    $

    20,482





    $

    16,853







    22

    %



    $

    37,284





    $

    31,943







    17

    %

    Total Net Sales



    $

    594,689





    $

    556,405







    7

    %



    $

    1,187,944





    $

    1,107,823







    7

    %









    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands, all amounts pre-tax)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Operating Income





































    Surfactants



    $

    13,367





    $

    17,062







    (22)

    %



    $

    42,297





    $

    43,142







    (2)

    %

    Polymers



    $

    17,159





    $

    13,597







    26

    %



    $

    25,177





    $

    21,979







    15

    %

    Specialty Products



    $

    5,258





    $

    7,319







    (28)

    %



    $

    10,766





    $

    11,587







    (7)

    %

    Total Segment

       Operating Income



    $

    35,784





    $

    37,978







    (6)

    %



    $

    78,240





    $

    76,708







    2

    %

    Corporate Expenses



    $

    (17,819)





    $

    (19,311)







    (8)

    %



    $

    (31,987)





    $

    (37,872)







    (16)

    %

    Consolidated

       Operating Income



    $

    17,965





    $

    18,667







    (4)

    %



    $

    46,253





    $

    38,836







    19

    %













    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in millions)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    EBITDA



    $

    50.6





    $

    47.9







    6

    %



    $

    108.6





    $

    98.0







    11

    %







































    Adjusted EBITDA





































       Surfactants



    $

    34.5





    $

    35.0







    (1)

    %



    $

    82.9





    $

    78.6







    5

    %

       Polymers



    $

    25.6





    $

    21.8







    17

    %



    $

    41.6





    $

    38.2







    9

    %

       Specialty Products



    $

    6.7





    $

    8.8







    (24)

    %



    $

    13.7





    $

    14.6







    (6)

    %

       Unallocated Corporate



    $

    (15.4)





    $

    (17.9)







    (14)

    %



    $

    (29.3)





    $

    (32.5)







    (10)

    %

    Consolidated Adjusted EBITDA



    $

    51.4





    $

    47.7







    8

    %



    $

    108.9





    $

    98.9







    10

    %

    Consolidated adjusted EBITDA(2) increased $3.7 million, or 8%, in the quarter.  This increase was primarily driven by Polymer sales volume growth of 7% and the non-recurrence of expenses associated with the external criminal social engineering fraud event in 2024.  Surfactant adjusted EBITDA was down slightly due to a 1% decline in sales volume.        

    • Surfactant net sales were $411.5 million for the quarter, an 8% increase versus the prior year.  Selling prices were up 11% primarily due to improved product and customer mix and the pass through of higher raw material costs.  Sales volume declined 1% year-over-year primarily due to lower demand within the commodity Laundry and Cleaning end markets that was largely offset by double digit growth within the Agricultural and Oilfield end markets.  Foreign currency translation negatively impacted net sales by 2%.  Surfactant adjusted EBITDA(2)  for the quarter decreased $0.5 million, or 1%, versus the prior year.  This decrease was primarily due to higher expenses associated with the start-up of our new alkoxylation facility in Pasadena, Texas, a Millsdale-related remediation reserve adjustment and an EPA penalty recognized in the second quarter of 2025.  Excluding these items, adjusted EBITDA was up double digits.  Current year adjusted EBITDA was also negatively impacted by higher Oleochemical raw material costs that we intend to recover via pricing in the second half of the year. 
    • Polymer net sales were $162.8 million for the quarter, a 2% increase versus the prior year.  Selling prices decreased 7%, primarily due to the pass-through of lower raw material costs and competitive pressures.  Sales volume increased 7% in the quarter.  North American Rigid, European Rigid and commodity Phthalic Anhydride sales volume was up year-over-year.  Foreign currency translation positively impacted net sales by 2% during the quarter.  Polymer adjusted EBITDA(2) increased $3.8 million, or 17%, versus the prior year primarily due to the 7% sales volume growth.    
    • Specialty Product net sales were $20.5 million for the quarter, a 22% increase versus the prior year, primarily due to higher sales volume.  Specialty Product adjusted EBITDA(2) decreased $2.1 million, or 24%.  The decrease in adjusted EBITDA(2) was primarily due to order timing fluctuations within the pharmaceutical business, as orders were moved from the second quarter to the second half of the year.

    Income Taxes

    The Company's effective tax rate was 19.2% in the first half of 2025 versus 36.1% in the first half of 2024.  This decrease was primarily attributable to a favorable tax audit settlement in 2025 combined with the non-recurrence of an unfavorable GILTI-related event in the first half of 2024.  These items were partially offset by the expected tax impact of certain cash repatriations to the United States.   

    Outlook

    "Looking forward, we remain focused on accelerating our business strategies through enhanced operational excellence, improved product and customer mix and accelerated free cash flow generation.  We believe our Surfactant business will experience continued growth in our key strategic end markets and that Polymer demand will continue improving as we get more market certainty and we execute our innovation and growth plans.  Our Pasadena facility is now operational, and as we have previously communicated, this will enable us to deliver volume growth in our alkoxylation product line and Supply Chain savings during the second half of the year,"  said Luis E. Rojo, President and Chief Executive Officer.  "We remain on track to close our asset sale in the Philippines during the fourth quarter and we will continue looking for opportunities to optimize our global footprint and asset base.  Despite all the current market uncertainties, including the impact of tariffs, we remain optimistic that we will deliver full year Adjusted EBITDA and Adjusted Net Income growth and positive free cash flow in 2025."

    Notes

    (1) Adjusted net income and adjusted earnings per share are non-GAAP measures which exclude deferred compensation income/expense, certain environmental remediation-related costs as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

    (2) EBITDA and adjusted EBITDA are non-GAAP measures.  See Table VI for calculations and GAAP reconciliations of EBITDA and adjusted EBITDA.

    (3) Free cash flow is a non-GAAP measure and reflects cash generated from operations minus capital expenditures.  Cash generated from operations was $11.2 million during the second quarter of 2025 and capital expenditures were $25.6 million. 

    Conference Call

    Stepan Company will host a conference call to discuss its second quarter results at 9:00 a.m. ET (8:00 a.m. CT) on July 30, 2025. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN.  To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time.  The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

    Supporting Slides

    Slides supporting this press release will be made available at www.stepan.com through the Investors/Presentations page at approximately the same time as this press release is issued.

    Corporate Profile

    Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

    Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. 

    The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

    More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com

    Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

    There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to  accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, changes in global trade policies, including tariffs; legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

    These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

    * * * * *

    Tables follow

    Table I



    STEPAN COMPANY

    For the Three and Six Months Ended June 30, 2025 and 2024

    (Unaudited – in 000's, except per share data)







    Three Months Ended

    June 30,





    Six Months Ended

    June 30,







    2025





    2024





    2025





    2024



    Net Sales



    $

    594,689





    $

    556,405





    $

    1,187,944





    $

    1,107,823



    Cost of Sales





    522,804







    486,853







    1,040,596







    967,990



    Gross Profit





    71,885







    69,552







    147,348







    139,833



    Operating Expenses:

























    Selling





    14,657







    11,828







    26,765







    23,216



    Administrative





    22,801







    24,569







    44,215







    47,259



    Research, Development and Technical Services





    14,701







    14,093







    29,350







    28,349



    Deferred Compensation Expense (Income)





    1,761







    395







    765







    2,173









    53,920







    50,885







    101,095







    100,997





























    Operating Income





    17,965







    18,667







    46,253







    38,836





























    Other Income (Expense):

























    Interest, Net





    (5,485)







    (2,661)







    (9,611)







    (5,732)



    Other, Net





    1,306







    1,200







    1,808







    3,562









    (4,179)







    (1,461)







    (7,803)







    (2,170)





























    Income Before Provision for Income Taxes





    13,786







    17,206







    38,450







    36,666



    Provision for Income Taxes





    2,445







    7,685







    7,398







    13,252



    Net Income





    11,341







    9,521







    31,052







    23,414



    Net Income Per Common Share

























    Basic



    $

    0.50





    $

    0.42





    $

    1.36





    $

    1.03



    Diluted



    $

    0.50





    $

    0.42





    $

    1.36





    $

    1.02



    Shares Used to Compute Net Income Per Common Share

























    Basic





    22,865







    22,827







    22,866







    22,825



    Diluted





    22,879







    22,936







    22,885







    22,942



     

    Table II



    Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share*







    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands, except per share amounts)



    2025





    EPS





    2024





    EPS





    2025





    EPS





    2024





    EPS



    Net Income Reported



    $

    11,341





    $

    0.50





    $

    9,521





    $

    0.42





    $

    31,052





    $

    1.36





    $

    23,414





    $

    1.02





















































    Deferred Compensation

       (Income) Expense



    $

    69





    $

    0.00





    $

    (305)





    $

    (0.01)





    $

    (401)





    $

    (0.02)





    $

    (693)





    $

    (0.03)



    Environmental Remediation

        Expense



    $

    542





    $

    0.02





    $

    180





    $

    -





    $

    611





    $

    0.03





    $

    1,331





    $

    0.06



    Adjusted Net Income



    $

    11,952





    $

    0.52





    $

    9,396





    $

    0.41





    $

    31,262





    $

    1.37





    $

    24,052





    $

    1.05



    * All amounts in this table are presented after-tax

    The Company believes that certain non-GAAP measures, in conjunction with comparable GAAP measures, are useful for evaluating the Company's operating performance and financial condition.  The Company uses this non-GAAP information as an indicator of business performance and evaluates management's effectiveness with specific reference to these indicators.  Management believes that these non-GAAP financial measures provide useful supplemental information because they exclude non-operational items that affect comparability between years.  These measures should be considered in addition to, not as substitutes for or superior to, measures of financial performance prepared in accordance with GAAP and may differ from similarly titled measures presented by other companies.  The Company's Annual Report on Form 10-K for the year ended December 31, 2024 contains additional information regarding the use of non-GAAP financial measures.

    Summary of Second Quarter 2025 Adjusted Net Income Items

    Adjusted net income excludes non-operational deferred compensation income/expense, certain environmental remediation costs and other significant and infrequent or non-recurring items.

    • Deferred Compensation: The second quarter of 2025 reported net income includes $0.1 million of after-tax expense versus $0.3 million of after-tax income in the prior year. 
    • Environmental Remediation: The second quarter of 2025 reported net income includes $0.5 million of after-tax expense versus $0.2 million of after-tax expense in the prior year. 

    Table III



    Reconciliation of Pre-Tax to After-Tax Adjustments



    Management uses the non-GAAP adjusted net income metric to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  The cumulative tax effect was calculated using the statutory tax rates for the jurisdictions in which the transactions occurred.







    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands, except per share amounts)



    2025





    EPS





    2024





    EPS





    2025





    EPS





    2024





    EPS



    Pre-Tax Adjustments

















































    Deferred Compensation (Income) Expense



    $

    92











    $

    (407)











    $

    (534)











    $

    (924)









    Environmental Remediation Expense



    $

    722











    $

    240











    $

    814











    $

    1,774









       Total Pre-Tax Adjustments



    $

    814











    $

    (167)











    $

    280











    $

    850



























































    Cumulative Tax Effect on Adjustments



    $

    (203)











    $

    42











    $

    (70)











    $

    (212)



























































    After-Tax Adjustments



    $

    611





    $

    0.02





    $

    (125)





    $

    (0.01)





    $

    210





    $

    0.01





    $

    638





    $

    0.03





































































     

    Table IV



    Deferred Compensation Plans



    The full effect of the deferred compensation plans on quarterly pre-tax income was $0.1 million of expense versus $0.4 million of income in the prior year.  The quarter-end market prices of Company stock and the impact of deferred compensation on specific income statement line items is summarized below:







    2025





    2024







    6/30





    3/31





    12/31





    9/30





    6/30





    3/31



    Stepan Company



    $

    54.58





    $

    55.04





    $

    64.70





    $

    77.25





    $

    83.96





    $

    90.04





















































     





    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands)



    2025





    2024





    2025





    2024



    Deferred Compensation

























    Operating Income (Expense)



    $

    (1,761)





    $

    (395)





    $

    (765)





    $

    (2,173)



    Other, net – Mutual Fund Gain (Loss)





    1,669







    802







    1,299







    3,097



    Total Pre-Tax



    $

    (92)





    $

    407





    $

    534





    $

    924



    Total After-Tax



    $

    (69)





    $

    305





    $

    401





    $

    693



    Effects of Foreign Currency Translation

    The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. These results are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period.  The table below presents the impact that foreign currency translation had on select income statement line items. 

    ($ in millions)



    Three Months

    Ended

    June 30,





    Change





    Change

    Due to

    Foreign

    Currency

    Translation





    Six Months Ended

    June 30,





    Change





    Change

    Due to

    Foreign

    Currency

    Translation







    2025





    2024

















    2025





    2024















    Net Sales



    $

    594.7





    $

    556.4





    $

    38.3





    $

    (1.7)





    $

    1,187.9





    $

    1,107.8





    $

    80.1





    $

    (20.2)



    Gross Profit





    71.9







    69.6





    $

    2.3







    (0.2)







    147.3







    139.8





    $

    7.5







    (2.8)



    Operating Income





    18.0







    18.7





    $

    (0.7)







    (0.2)







    46.3







    38.8





    $

    7.5







    (2.0)



    Pretax Income





    13.8







    17.2





    $

    (3.4)







    (0.2)







    38.5







    36.7





    $

    1.8







    (2.1)



    Corporate Expenses





    Three Months Ended

    June 30,





    Six Months Ended

    June 30,



    ($ in thousands)



    2025





    2024





    %

    Change





    2025





    2024





    %

    Change



    Total Corporate Expenses



    $

    17,819





    $

    19,311







    (8)

    %



    $

    31,987





    $

    37,872







    (16)

    %

    Less:





































       Deferred Compensation (Income) Expense



    $

    1,761





    $

    395







    346

    %



    $

    765





    $

    2,173







    (65)

    %

       Environmental Remediation

          Expense



    $

    722





    $

    240







    201

    %



    $

    814





    $

    1,774







    (54)

    %

    Adjusted Corporate Expenses



    $

    15,336





    $

    18,676







    (18)

    %



    $

    30,408





    $

    33,925







    (10)

    %

    Adjusted Corporate expenses decreased $3.3 million, or 18% for the quarter.  This decrease was primarily due to the non-recurrence of expenses associated with a criminal social engineering scheme in 2024.

     

    Table V







    Stepan Company



    Consolidated Balance Sheets



    June 30, 2025 and December 31, 2024











    June 30, 2025





    December 31, 2024



    ASSETS













    Current Assets



    $

    906,106





    $

    810,429



    Property, Plant & Equipment, Net





    1,212,928







    1,198,454



    Other Assets





    297,096







    295,765



    Total Assets



    $

    2,416,130





    $

    2,304,648



    LIABILITIES AND STOCKHOLDERS' EQUITY













    Current Liabilities



    $

    673,273





    $

    669,034



    Deferred Income Taxes





    10,385







    9,612



    Long-term Debt





    383,239







    332,632



    Other Non-current Liabilities





    107,520







    123,436



    Total Stepan Company Stockholders' Equity





    1,241,713







    1,169,934



    Total Liabilities and Stockholders' Equity



    $

    2,416,130





    $

    2,304,648



    Selected Balance Sheet Information 

    The Company's total debt decreased by $1.3 million and cash decreased by $18.6 million versus March 31, 2025.  The Company's net debt level increased $17.3 million versus March 31, 2025 and the net debt ratio remained constant at 31% in the quarter (Net Debt and Net Debt Ratio are non-GAAP measures, reconciliations of which are shown in the table below).  Management uses the non-GAAP net debt metric to show a more complete picture of the Company's overall liquidity, financial flexibility and leverage level. 

    ($ in millions)



    June 30,

    2025





    March 31,

    2025





    December 31,

    2024



    Net Debt



















    Total Debt



    $

    658.0





    $

    659.3





    $

    625.4



    Cash





    88.9







    107.5







    99.7



    Net Debt



    $

    569.1





    $

    551.8





    $

    525.7



    Equity





    1,241.7







    1,200.5







    1,169.9



    Net Debt + Equity



    $

    1,810.8





    $

    1,752.3





    $

    1,695.6



    Net Debt / (Net Debt + Equity)





    31

    %





    31

    %





    31

    %

    The major working capital components were:

    ($ in millions)



    June 30,

    2025





    March 31,

    2025





    December 31,

    2024



    Net Receivables



    $

    442.2





    $

    436.5





    $

    388.0



    Inventories





    329.5







    309.3







    288.7



    Accounts Payable





    (281.8)







    (298.1)







    (258.8)







    $

    489.9





    $

    447.7





    $

    417.9



     

    Table VI



    Reconciliations of Non-GAAP EBITDA and Adjusted EBITDA



    Management uses the non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the Company's operating performance.  Management excludes the items listed in the table below because they are non-operational items.  Refer to the Income Statement on Table I for a bridge between Operating Income and Net Income.







    Three Months Ended

    June 30, 2025



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    13.4





    $

    17.2





    $

    5.2





    $

    (17.8)





    $

    18.0



       Depreciation and Amortization



    $

    21.1





    $

    8.4





    $

    1.5





    $

    0.3





    $

    31.3



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    1.3





    $

    1.3



    EBITDA



























    $

    50.6



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    0.1





    $

    0.1



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    0.7





    $

    0.7



    Adjusted EBITDA



    $

    34.5





    $

    25.6





    $

    6.7





    $

    (15.4)





    $

    51.4







































    Three Months Ended

    June 30, 2024



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    17.1





    $

    13.6





    $

    7.3





    $

    (19.3)





    $

    18.7



       Depreciation and Amortization



    $

    17.9





    $

    8.2





    $

    1.5





    $

    0.4





    $

    28.0



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    1.2





    $

    1.2



    EBITDA



























    $

    47.9



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (0.4)





    $

    (0.4)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    0.2





    $

    0.2



    Adjusted EBITDA



    $

    35.0





    $

    21.8





    $

    8.8





    $

    (17.9)





    $

    47.7











    Six Months Ended

    June 30, 2025



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    42.3





    $

    25.2





    $

    10.8





    $

    (32.0)





    $

    46.3



       Depreciation and Amortization



    $

    40.6





    $

    16.4





    $

    2.9





    $

    0.6





    $

    60.5



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    1.8





    $

    1.8



    EBITDA



























    $

    108.6



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (0.5)





    $

    (0.5)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    0.8





    $

    0.8



    Adjusted EBITDA



    $

    82.9





    $

    41.6





    $

    13.7





    $

    (29.3)





    $

    108.9







































    Six Months Ended

    June 30, 2024



































    ($ in millions)



    Surfactants





    Polymers





    Specialty

    Products





    Unallocated

    Corporate





    Consolidated



    Operating Income



    $

    43.1





    $

    22.0





    $

    11.6





    $

    (37.9)





    $

    38.8



       Depreciation and Amortization



    $

    35.5





    $

    16.2





    $

    3.0





    $

    0.9





    $

    55.6



       Other, Net Income



    $

    -





    $

    -





    $

    -





    $

    3.6





    $

    3.6



    EBITDA



























    $

    98.0



       Deferred Compensation



    $

    -





    $

    -





    $

    -





    $

    (0.9)





    $

    (0.9)



       Environmental Remediation



    $

    -





    $

    -





    $

    -





    $

    1.8





    $

    1.8



    Adjusted EBITDA



    $

    78.6





    $

    38.2





    $

    14.6





    $

    (32.5)





    $

    98.9



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/stepan-reports-second-quarter-2025-results-302517180.html

    SOURCE Stepan Company

    Get the next $SCL alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SCL

    DatePrice TargetRatingAnalyst
    10/19/2023$89.00Neutral → Buy
    CL King
    3/11/2022$9.00 → $8.00Outperform
    RBC Capital
    12/20/2021$8.50 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $SCL
    SEC Filings

    View All

    SEC Form 10-Q filed by Stepan Company

    10-Q - STEPAN CO (0000094049) (Filer)

    8/6/25 10:43:36 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - STEPAN CO (0000094049) (Filer)

    7/30/25 7:00:33 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 8-K filed by Stepan Company

    8-K - STEPAN CO (0000094049) (Filer)

    7/14/25 7:12:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    V.P. and Gen'l. Mgr., Polymers Stepan Richard Finn transferred by will 23,124 shares), increasing direct ownership by 9% to 241,020 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    8/14/25 1:50:10 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Stepan F Quinn Jr transferred by will 161,869 shares) and transferred by will 23,124 shares), increasing direct ownership by 20% to 126,123 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    8/14/25 1:44:14 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Painter Corning F. was granted 2,433 shares (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    8/12/25 4:31:43 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lewis Susan bought $31,765 worth of shares (500 units at $63.53), increasing direct ownership by 36% to 1,896 units (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    2/27/25 8:57:39 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    VP GC & Secretary Kabbes David bought $75,388 worth of shares (1,056 units at $71.39) (SEC Form 4)

    4 - STEPAN CO (0000094049) (Issuer)

    8/15/24 1:19:55 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stepan Company upgraded by CL King with a new price target

    CL King upgraded Stepan Company from Neutral to Buy and set a new price target of $89.00

    10/19/23 9:02:32 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    RBC Capital reiterated coverage on Shawcor with a new price target

    RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $8.00 from $9.00 previously

    3/11/22 7:14:07 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    RBC Capital reiterated coverage on Shawcor with a new price target

    RBC Capital reiterated coverage of Shawcor with a rating of Outperform and set a new price target of $9.00 from $8.50 previously

    12/20/21 6:55:29 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stepan Reports Second Quarter 2025 Results

    NORTHBROOK, Ill., July 30, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Second Quarter 2025 Highlights Reported net income was $11.3 million, up 19% versus the prior year.  Adjusted net income(1) was $12.0 million, up 27% versus the prior year, driven by earnings growth within Polymers, our Crop Productivity business and a lower effective tax rate. EBITDA(2)  was $50.6 million and Adjusted EBITDA(2) was $51.4 million, up 6% and 8% respectively, year-over-year.Global sales volume was up 1% year-over-year.       Cash from Operations was $11.2 million during the

    7/30/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Declares Quarterly Dividend

    NORTHBROOK, Ill., July 30, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.385 per share. The dividend is payable on September 15, 2025, to common stockholders of record on August 29, 2025. The Company increased its quarterly cash dividend in the fourth quarter of 2024 by $0.010 per share, marking the 57th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of s

    7/30/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Reminder: Stepan to Announce Second Quarter 2025 Results on July 30, 2025

    NORTHBROOK, Ill., July 23, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its second quarter 2025 earnings results on Wednesday, July 30, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Ruben Velasq

    7/23/25 5:05:00 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Financials

    Live finance-specific insights

    View All

    Stepan Reports Second Quarter 2025 Results

    NORTHBROOK, Ill., July 30, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: Second Quarter 2025 Highlights Reported net income was $11.3 million, up 19% versus the prior year.  Adjusted net income(1) was $12.0 million, up 27% versus the prior year, driven by earnings growth within Polymers, our Crop Productivity business and a lower effective tax rate. EBITDA(2)  was $50.6 million and Adjusted EBITDA(2) was $51.4 million, up 6% and 8% respectively, year-over-year.Global sales volume was up 1% year-over-year.       Cash from Operations was $11.2 million during the

    7/30/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Declares Quarterly Dividend

    NORTHBROOK, Ill., July 30, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.385 per share. The dividend is payable on September 15, 2025, to common stockholders of record on August 29, 2025. The Company increased its quarterly cash dividend in the fourth quarter of 2024 by $0.010 per share, marking the 57th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of s

    7/30/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Reminder: Stepan to Announce Second Quarter 2025 Results on July 30, 2025

    NORTHBROOK, Ill., July 23, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) will issue its second quarter 2025 earnings results on Wednesday, July 30, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Ruben Velasq

    7/23/25 5:05:00 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Leadership Updates

    Live Leadership Updates

    View All

    Stepan Announces Appointment of New Vice President and Chief Financial Officer

    NORTHBROOK, Ill., July 14, 2025 /PRNewswire/ -- Stepan Company (NYSE:SCL) announced today the appointment of Ruben Velasquez as Vice President and Chief Financial Officer of Stepan, effective as of July 15, 2025. Mr. Velasquez will succeed Samuel Hinrichsen who, as previously reported, is presently serving as Vice President and Interim Chief Financial Officer. Mr. Hinrichsen will continue in his role as Vice President of Finance. Mr. Velasquez most recently served as Vice President Global Finance Transformation at 3M Company. Prior to that, Mr. Velasquez held several senior fi

    7/14/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Company Announces Appointment of New Director

    NORTHBROOK, Ill., June 9, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) announced today the appointment of Corning Painter as a Director of Stepan, effective immediately. Mr. Painter currently serves as Chief Executive Officer of Orion S.A., a global chemical manufacturer, a role he has held since September of 2018. Prior to joining Orion, Mr. Painter was an Executive Vice President for Industrial Gases at Air Products and Chemicals, an industrial gas company, which Mr. Painter joined in 1984. Mr. Painter is a Certified Professional Engineer and holds a chemical engineering

    6/9/25 7:00:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

    NORTHBROOK, Ill., Oct. 30, 2024 /PRNewswire/ -- Stepan Company (NYSE:SCL) today announced the appointment of Luis E. Rojo as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately. After a 31-year Stepan career, Scott R. Behrens is departing the Company to pursue other opportunities. "We thank Scott for his leadership and his many contributions to the growth and diversification of Stepan over his career with the Company. During his various roles in R&D, sales and marketing, and leadership, he helped diversify our market presence,

    10/30/24 6:55:00 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    $SCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Stepan Company

    SC 13G - STEPAN CO (0000094049) (Subject)

    2/9/24 9:59:18 AM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Stepan Company (Amendment)

    SC 13G/A - STEPAN CO (0000094049) (Subject)

    1/24/24 12:33:12 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Stepan Company (Amendment)

    SC 13G/A - STEPAN CO (0000094049) (Subject)

    1/22/24 3:52:11 PM ET
    $SCL
    Package Goods/Cosmetics
    Consumer Discretionary